金河生物
(002688)
| 流通市值：36.92亿 | | | 总市值：41.28亿 |
| 流通股本：7.49亿 | | | 总股本：8.37亿 |
| 利润表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 营业总收入 | 1,447,664,288.35 | 741,878,953.16 | 2,878,096,341.01 | 2,036,199,952.22 |
| 营业总成本 | 1,271,446,475.34 | 664,708,394.86 | 2,663,177,540.53 | 1,893,954,187.39 |
| 其他经营收益 | | | | |
| 营业利润 | 177,233,089.61 | 76,876,281.51 | 42,475,205.19 | 161,808,518.5 |
| 利润总额 | 176,503,553.57 | 76,972,676.9 | 39,146,659.02 | 160,750,511.35 |
| 净利润 | 135,176,895.88 | 63,340,872.31 | -10,984,967.97 | 134,780,194.66 |
| 每股收益 | | | | |
| 其他综合收益 | -23,020,964.45 | -10,987,690.87 | -14,129,234.68 | -7,213,099.45 |
| 综合收益总额 | 112,155,931.43 | 52,353,181.44 | -25,114,202.65 | 127,567,095.21 |
| 资产负债表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 流动资产: | | | | |
| 流动资产合计 | 2,229,384,963.76 | 2,395,077,940.5 | 2,057,835,055.44 | 1,918,325,119.42 |
| 非流动资产: | | | | |
| 非流动资产合计 | 3,435,305,619.36 | 3,422,206,134.59 | 3,461,104,701.32 | 3,666,645,990.76 |
| 资产总计 | 5,664,690,583.12 | 5,817,284,075.09 | 5,518,939,756.76 | 5,584,971,110.18 |
| 流动负债: | | | | |
| 流动负债合计 | 1,893,547,278.72 | 1,845,339,108.39 | 1,802,174,275.84 | 2,040,548,952.94 |
| 非流动负债: | | | | |
| 非流动负债合计 | 1,284,314,294.06 | 1,472,534,060.22 | 1,273,424,194.5 | 944,677,335.87 |
| 负债合计 | 3,177,861,572.78 | 3,317,873,168.61 | 3,075,598,470.34 | 2,985,226,288.81 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 2,271,055,502.25 | 2,285,071,412.79 | 2,228,397,414.47 | 2,349,509,857.26 |
| 股东权益合计 | 2,486,829,010.34 | 2,499,410,906.48 | 2,443,341,286.42 | 2,599,744,821.37 |
| 负债和股东权益合计 | 5,664,690,583.12 | 5,817,284,075.09 | 5,518,939,756.76 | 5,584,971,110.18 |
| 现金流量表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 1,517,251,596.96 | 681,971,851.03 | 2,924,099,565.07 | 2,140,500,460.72 |
| 经营活动现金流出小计 | 1,263,247,497.49 | 663,337,472.66 | 2,455,180,035.41 | 1,776,252,875.16 |
| 经营活动产生的现金流量净额 | 254,004,099.47 | 18,634,378.37 | 468,919,529.66 | 364,247,585.56 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 6,728,447.02 | 5,020,108.22 | 5,681,138 | 4,667,030 |
| 投资活动现金流出小计 | 144,128,425.68 | 87,275,331.61 | 320,278,143.93 | 218,199,577.37 |
| 投资活动产生的现金流量净额 | -137,399,978.66 | -82,255,223.39 | -314,597,005.93 | -213,532,547.37 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 905,867,748.95 | 845,184,611.83 | 1,623,537,508.67 | 1,064,959,959.78 |
| 筹资活动现金流出小计 | 929,556,158.56 | 560,136,130.09 | 1,747,060,731.99 | 1,283,602,160.92 |
| 筹资活动产生的现金流量净额 | -23,688,409.61 | 285,048,481.74 | -123,523,223.32 | -218,642,201.14 |
| 汇率变动对现金及现金等价物的影响 | -7,905,022.85 | -482,447.91 | -4,070,922.05 | -763,289.29 |
| 现金及现金等价物净增加额 | 85,010,688.35 | 220,945,188.81 | 26,728,378.36 | -68,690,452.24 |
| 期末现金及现金等价物余额 | 700,087,156.41 | 836,021,656.87 | 615,076,468.06 | 519,657,637.46 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | 85,010,688.35 | - | 26,728,378.36 | - |